Bayer hits back at Iberogast critics
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
Bayer Consumer Health has instigated a pharmacy marketing campaign defending its Iberogast gastrointestinal brand following a series of attacks from a German Member of Parliament (MP).